Drug Profile
SLV 316
Latest Information Update: 03 Mar 2010
Price :
$50
*
At a glance
- Originator Solvay
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cardiovascular disorders
Most Recent Events
- 06 May 2005 This compound is still in active development
- 13 Dec 2001 New profile
- 13 Dec 2001 Preclinical development for Cardiovascular disorders (Unknown route)